- •Acknowledgment
- •Abbreviations and Glossary
- •Contents
- •Introduction
- •1: Should You Become a VR Surgeon?
- •2.2 A Word of Caution
- •Introduction
- •3: Fundamental Rules for the VR Surgeon
- •3.4 The “What, When, How – and Why” Questions
- •3.5 Don’t Start What You Cannot Finish
- •3.6 Common Sense vs Dogma
- •3.7 Maximal Concentration During the Entire Operation
- •3.8 Make Life as Easy for Yourself as Possible
- •3.9 Under Peer Pressure: To Yield or Not to Yield
- •3.10 Referral of the Patient
- •3.11 The Rest of the Eyeball…
- •4.1 What If the Surgeon Has Tremor?
- •4.2 How Important Is Good Dexterity?
- •4.5 Combined Surgery or Cataract Surgery Separately?
- •4.7 How Much Confidence in Himself Should the VR Surgeon Have?
- •4.8 How Long Do Vitrectomies Take?
- •4.9 Was Surgery Successful?
- •5.1 The “Target” of Counseling
- •5.2 The Patient Does Not Know Most of What Is so Obvious to the Surgeon
- •5.3 Communicating with the Patient
- •5.4 Coaching vs Trying to Be Objective
- •5.5 The Ultimate Treatment Decision: “Whose Eye Is It?”
- •5.6 Which of the Two Eyes to Operate on First?
- •5.7 What if the Eye Has Two Diseases?
- •5.8 What if the Eye Has Severe Visual Loss and the Chance of Improvement with Another Surgery Is Low?
- •5.9 Empathy: The Single Most Important Component of Counseling
- •5.10 The Prognosis with the Chosen Surgical Option
- •5.11 If the Patient Chooses to Undergo Surgery
- •5.12 The Benefits of Proper Counseling
- •5.14 The Dogmas
- •6: The VR Surgeon’s Relation to His Nurse
- •7: Examination
- •8: The Indication Whether to Operate
- •8.1 The Argument in Favor of Surgery
- •8.3 The Age of the Patient
- •8.4 The Condition of the Fellow Eye
- •11: The Surgeon’s Relation to Himself
- •11.3 Self-Examination
- •Introduction
- •12.1.1 The Pump
- •12.1.1.1 Peristaltic Pump: Flow Control
- •12.1.2 The Probe
- •12.1.2.2 Port Location
- •12.1.2.3 Port Configuration and Size
- •12.1.2.4 Cut Rate
- •12.1.2.6 Probe Length
- •12.1.3 The Light Source/Pipe
- •12.1.4 The Infusion Supply
- •12.1.5 The Trocar
- •12.1.6 The Cannula
- •12.1.7 System to Inject/Extract Viscous Fluid
- •12.1.8 The Pedal
- •12.1.10 Endodiathermy Probe
- •12.1.11 The User Interface of the Vitrectomy Console
- •12.1.12 Troubleshooting
- •12.2 The Microscope
- •13: Instruments, Tools, and Their Use
- •13.2.1.1 General Concepts of Working with Squeezable Instruments
- •13.2.1.2 The Handle
- •13.2.1.3 Forceps
- •13.2.1.4 Scissors
- •13.2.2 Hybrid Instruments
- •13.2.2.2 Retractable Instruments
- •13.2.3 Non-squeezable Hand Instruments
- •13.2.3.1 Bent (Hooked, Barbed) Needle
- •13.2.3.2 Membrane Scraper
- •13.2.3.3 Spatula/Pic
- •13.2.3.4 Intraocular Magnet
- •13.3.1 Membrane Dissection (“Viscosurgery”): Viscoelastics as a Spatula
- •13.3.2 Opening a Closed Funnel
- •14: Materials and Their Use
- •14.2 Intravitreal Gas
- •14.3 Silicone Oil
- •14.3.1 Types of Silicone Oil
- •14.3.3 Complications Related to Silicone Oil Use
- •14.3.4 Complications Related to Silicone Oil Use Removal
- •14.4 PFCL
- •14.6 Sutures
- •15: Anesthesia
- •15.1 How to Decide the Type of Anesthesia
- •15.2 If Local Anesthesia Is Chosen
- •15.3 Medications If Local Anesthesia Is Used
- •16: The Surgeon at the Operating Table
- •16.1 The OR Personnel
- •16.2 The Operating Table and the Surgeon’s Chair
- •16.2.1 The Operating Table
- •16.2.2 The Surgeon’s Chair
- •16.4 The Microscope
- •16.5 The BIOM
- •16.5.1 BIOM: The Advantages
- •16.5.2 BIOM Use: Practical Information
- •16.5.3 BIOM: Setting Up for Daily Use
- •16.5.4 BIOM: Checklist
- •16.5.5 BIOM: Troubleshooting
- •16.6 The Patient
- •16.7 The Surgeon
- •16.7.2 At the Start of Vitrectomy
- •16.7.3 Staring into the Microscope
- •16.8 Music in the OR
- •16.9 The Brightness in the OR
- •16.10 The Quality of the Air in the OR
- •16.12 The Blueprint of the OR
- •16.13 The Captain in the OR
- •16.14 The Fundamental Technical Rules of Performing Intravitreal Surgery
- •Introduction
- •17.3 The Endoscope Approach (EAV)
- •17.4 Portable Systems
- •17.5 3D Viewing
- •18.1 Disinfection and Draping
- •18.2 The Monocular Patient
- •18.3 At the Conclusion of the Operation
- •19: The Speculum and Its Placement
- •19.1 General Considerations
- •19.2 Speculum Placement
- •20.3 Injecting into the Vitreous Cavity During Surgery
- •21: Sclerotomies and the Cannulas
- •21.2 Location of the Sclerotomies
- •21.2.1 Distance from the Limbus
- •21.2.2 Location in Clock Hours
- •21.2.3 In Case of a Reoperation
- •21.2.4 In Case of Scleral Thinning
- •21.3 Inserting the Cannula
- •21.4 The Order of Cannula Placement
- •21.5 If the Palpebral Opening Is Small
- •21.6 Checking the (Infusion) Cannula
- •21.6.1 Cannula Under the Choroid/Retina: Prevention
- •21.6.2 Cannula Under the Choroid/Retina: Management
- •21.6.3 Infusion Going Under the Choroid/Retina: Management
- •21.7 The Cannulas in Use
- •21.8 The Removal of the Cannulas
- •21.8.1 Hypotony: The Causes
- •21.8.2 Hypotony: The Consequences
- •21.8.3 Hypotony: Prevention
- •21.8.4 Hypotony: Postoperative Management
- •22: Illumination
- •22.1 The Light Pipe
- •22.3 Light Built into the Handheld Instruments
- •24: Using the Vitrectomy Probe
- •24.1 Removal of the Vitreous
- •24.2 Removal of Proliferative Membranes
- •24.3 Removal of the Retina
- •24.4 Removal of the Lens
- •25: Maintaining Good Visualization
- •25.1.1 The Microscope
- •25.1.2 The Contact Lens
- •25.1.3 The Corneal Surface
- •25.1.4 The Corneal Stroma
- •25.2 Internal Factors
- •25.2.2 Pupil
- •25.2.2.1 Mechanical Forces Preventing Pupil Dilation
- •25.2.2.2 Intracameral Adrenalin or Visco
- •25.2.2.4 Iris Ring
- •25.2.2.5 Iridotomy
- •25.2.3 Lens
- •25.2.3.1 Cataract
- •25.2.3.2 “Feathering”
- •25.2.3.3 “Gas Cataract”
- •25.2.3.4 “Lens Touch”
- •25.2.4.1 Phimosis of the Anterior Capsule
- •25.2.4.2 Deposit on the Anterior IOL Surface
- •25.2.4.3 Problems with the IOL Itself
- •25.2.4.4 Fluid Condensation
- •25.2.5 The Posterior Capsule
- •25.2.6 The Vitreous Cavity
- •25.2.7 Epiretinal (Subhyaloidal) Materials
- •25.2.7.1 Blood
- •25.2.8 The Surgeon’s Actions
- •25.2.9 “Chromovitrectomy”
- •26.1.1 Vitreous Macroanatomy
- •26.1.2 Vitreous Biochemistry and Its Anatomical and Functional Implications
- •26.1.3 Retinal Histology and Macroanatomy
- •26.1.4 Anterior Segment Dimensions
- •26.2 External Anatomy for the VR Surgeon
- •26.3 Physiology: What Keeps the Retina Attached?
- •26.3.1 The RPE Pump
- •26.3.3 Presence of the Vitreous Gel
- •27: The Basics of Vitreous Removal
- •27.1 The Rationale for PPV
- •27.2 How Much Vitreous to Remove?
- •27.3 Recognizing the Presence of the Vitreous Gel
- •27.3.1 Mechanical Aids
- •27.3.2 Air (Pneumovitrectomy)
- •27.3.3 Stains and Markers
- •27.4 The Sequence of Vitreous Removal
- •27.5.2 Vitrectomy Anterior to the Equator
- •27.5.3 Vitrectomy Behind the Lens
- •28: Scleral Indentation
- •28.1 The Advantages of Scleral Indentation
- •28.2 The Mechanics of Vitrectomy with Scleral Indentation
- •28.3 Internal vs External Illumination
- •28.5 External Illumination and Nurse Indentation
- •28.6 Instrumentation and Technique
- •29: Cryopexy
- •29.1 Indication in RD
- •29.2 Surgical Technique
- •29.3 Cryopexy as a Destructive Force
- •30: Endolaser
- •30.1 The Consequences of Laser Treatment
- •30.2 The Setup
- •30.3 The Technique of Endolaser Treatment
- •30.3.1 General Considerations
- •30.3.2 Panretinal Treatment
- •30.3.3 Endolaser Cerclage and Its Complications
- •30.3.4 Endolaser as a Walling-Off (Barricading) Tool
- •30.3.5 Endolaser as a Welding Tool
- •30.4 Peripheral Laser and the Beginner VR Surgeon
- •30.5 Endocyclophotocoagulation
- •30.6 Laser Cerclage at the Slit Lamp
- •31: Working With and Under Air
- •31.1.1 Attached Retina
- •31.3 The Utilization of an Air Bubble
- •32: Working with Membranes
- •32.1.1 Instrumentation and Infrastructure
- •32.1.2 Opening the ILM
- •32.1.2.1 Sharp Opening: Incision First
- •32.1.2.2 Blunt Opening: No Incision
- •The Scraper
- •32.1.3 Peeling the Membrane
- •32.1.4 The Extent of ILM Peeling
- •32.1.5 What If the ILM Cannot Be Peeled?
- •32.1.6 ILM Removal in Eyes with Detached Macula
- •32.1.6.1 Reattaching the Macula First
- •32.1.6.2 Peeling When the Macula Is Still Detached
- •32.2.2 Removal Technique
- •32.2.2.1 Staining or Not?
- •32.2.2.2 Instrumentation
- •32.2.2.3 Location of the Point of Attack
- •32.2.2.4 The Major Risks When First Grabbing an EMP
- •32.2.2.5 The Direction of Peeling: Centripetal vs Centrifugal
- •32.2.2.6 The Speed of Peeling
- •32.2.2.7 The Extent of Peeling
- •32.2.2.8 ILM Peeling
- •32.2.2.9 Completion of Surgery
- •32.3.1.1 Recognition
- •32.3.1.2 The Goals of Surgery
- •32.3.1.3 Instrumentation
- •32.3.1.4 Surgical Steps
- •32.3.1.5 Closed Funnel/Retinal Incarceration
- •32.3.1.6 ILM Removal
- •32.4 Subretinal Membranes/Strands
- •33.1 Retinectomy
- •34: Chromovitrectomy
- •34.1 Posterior Vitreous Cortex
- •34.3.1 False-Positive Staining with ICG
- •34.3.2 Injection Technique for Staining the ILM
- •34.4 Newly Formed (PVR) Membranes
- •35: Tamponades
- •35.2 Gases
- •35.2.1 General Considerations
- •35.2.3 Gas Injection into the Nonvitrectomized Eye
- •35.2.4 The Eye with Gaseous Tamponade
- •35.3.1 Indications to Use Heavier-Than-Water Liquids
- •35.3.2 Surgical Technique
- •35.3.2.1 Implantation
- •35.4 Silicone Oil
- •35.4.1 Selecting the Type of Silicone Oil to Implant
- •35.4.2 General Considerations
- •35.4.3 Indications
- •35.4.3.1 Semipermanent Tamponade
- •35.4.3.2 Permanent Tamponade
- •35.4.4 Implantation
- •35.4.5 With Silicone Oil in the Eye
- •35.4.5.1 General Considerations
- •35.4.5.2 Emulsification
- •35.4.6 Removal
- •35.4.6.1 Timing
- •35.4.6.2 Surgical Technique
- •35.5 Exchanges
- •35.6 If the Eye Is Aphakic
- •36: Submacular Hemorrhage
- •36.1 The Nonsurgical Approach: Intravitreal Gas and tPA
- •36.2 Removal of the Clot In Toto
- •36.4 The Minimalistic Surgical Approach
- •37: Subretinal Biopsy
- •38: Combined Surgery
- •38.1 Phacoemulsification
- •38.2 Lensectomy
- •38.2.1 Lens In Situ
- •38.3.1 Lens In Situ
- •38.3.2 Lens in Vitreous
- •38.4.2 No IOL Implantation
- •38.5 Capsule Removal
- •38.5.1 Indications
- •38.5.2 Surgical Technique
- •38.6.1 Advantages
- •38.6.2 Surgical Technique
- •38.6.3 Subsequent Sub/luxation of an Iris-Claw IOL
- •38.6.3.1 Subluxated Lens
- •38.6.3.2 Luxated Lens
- •39: AC Basics
- •39.1 Paracentesis
- •39.2 Iris Prolapse
- •39.3 Anterior Synechia
- •39.5 Material in the AC
- •40.2 Retinal Tear
- •40.3 Reopening of a Posterior Scleral Wound
- •40.4 Lens/IOL Trauma
- •41: Pediatric Patients
- •42: The Highly Myopic Eye
- •42.1 The Risk of RD If Cataract Surgery Is Needed
- •42.2 Vitrectomy in the Highly Myopic Eye
- •42.3 Posterior RD over a Staphyloma
- •43: Intravitreal Injections
- •Introduction
- •44: Dropped Nucleus and Dislocated IOL
- •44.1 General Considerations
- •44.1.2 Dislocated IOL
- •44.2 Surgical Technique
- •44.2.1 Dropped Nucleus
- •45: Endophthalmitis
- •45.1 General Considerations
- •45.1.1 Etiology
- •45.1.2 Clinical Diagnosis
- •45.1.3 Timing
- •45.1.4 Treatment Options and Management Philosophy
- •45.2 Surgical Technique
- •45.3 Posttraumatic Endophthalmitis
- •46: Floaters
- •46.1 General Considerations
- •46.1.1 Indication for Surgery
- •46.1.2 Timing of Surgery
- •46.2 Surgical Technique
- •47: Hyphema
- •47.1 General Considerations
- •47.1.1 The Rationale for Surgical Removal
- •47.1.2 Medical Treatment
- •47.2 Surgical Technique
- •47.2.1 Liquid Blood
- •47.2.1.1 Monomanual Technique
- •47.2.1.2 Bimanual Technique
- •47.2.2 Clotted Blood
- •48: Iris Abnormalities
- •48.1 General Considerations
- •48.1.2 Timing of Iris Reconstruction
- •48.2 Surgical Technique
- •48.2.2 Iridodialysis
- •48.2.3 Permanent Mydriasis
- •49: Macular Disorders: Edema
- •49.1 General Considerations
- •49.1.1 Etiology
- •49.1.2 Indications for Treatment: Surgical or Nonsurgical?
- •50.1 General Considerations
- •50.1.1 VMTS
- •50.1.2 Cellophane Maculopathy
- •50.1.3 Macular Pucker
- •50.1.4 Macular Hole
- •50.2.1 VMTS
- •50.2.2 Cellophane Maculopathy
- •50.2.3 Macular Pucker
- •50.2.4 Macular Hole
- •50.2.5 If Surgery Failed for a Macular Hole
- •51: Optic Pit
- •51.1 General Considerations
- •51.2 Surgical Technique
- •52.1 General Considerations
- •52.1.1 Indications
- •52.1.2 Preoperative Considerations
- •52.2 Surgical Technique
- •53.1 General Considerations
- •53.2 Surgical Technique
- •54: Retinal Detachment
- •54.1.1 RD Due to a Horseshoe or Giant Tear
- •54.1.2 RD Due to a Dialysis
- •54.1.3 RD Due to a Round Hole
- •54.1.4 RD Due to a Staphyloma
- •54.2 Additional Information About RD
- •54.2.1 History
- •54.2.3 Clinical Course
- •54.2.4 Using Laser to Prevent RD Development
- •54.2.4.1 Prophylaxis in the Affected Eye (RD, Current or Past)
- •54.2.4.2 Prophylaxis in the Fellow Eye
- •54.2.4.3 The Patient with a History of a Retinal Tear (No RD)
- •54.3 Treatment Principles
- •54.3.2 The Goals of Surgery
- •54.3.3 Prognosis
- •54.4.1 Preoperatively
- •54.4.2.1 Initial Steps
- •54.4.2.2 Creating a Chorioretinal Adhesion
- •54.4.2.3 Drainage of the Subretinal Fluid
- •54.4.2.5 Suturing
- •54.4.2.7 Adjusting the Buckle
- •54.4.2.8 Closing the Conjunctiva
- •54.4.2.9 Gas Tamponade
- •54.4.3 Major Intraoperative Complications of SB
- •54.5 Vitrectomy
- •54.5.2.3 Intraoperative Retinal Reattachment
- •54.5.2.4 Laser Retinopexy
- •54.5.2.5 Intraocular Tamponade
- •54.5.2.6 Postoperative Positioning
- •54.5.3 Follow-Up Visits
- •54.5.4 Prognosis
- •54.5.5 RD After Silicone Oil Removal
- •54.6 Pneumatic Retinopexy
- •54.6.1 General Considerations
- •54.6.2 Patient Selection
- •54.6.3 Surgical Options
- •54.6.3.1 Cryopexy, Followed by Gas Injection
- •54.6.3.2 Gas Injection, Followed by Laser
- •54.7 Reoperation
- •55: RD, Tractional and Combined
- •55.1.1 Characteristics of the RD
- •55.1.2 Management Principles
- •56: RD, Central
- •56.1 General Considerations
- •56.2 Surgical Technique
- •57: Retinoschisis
- •57.1.1 Anatomy and Pathophysiology
- •57.1.2 Prophylactic Laser Treatment
- •57.2 Surgical Technique
- •58.1 General Considerations
- •58.1.1 Treatment Options
- •58.1.2 The Vitrectomy Option
- •58.2 Surgical Technique
- •59: Scleroplasty
- •59.1 General Considerations
- •59.2 Surgical Technique
- •60: Suprachoroidal Hemorrhage
- •60.1.1 Indications for Surgery
- •60.1.2 Timing of Surgery
- •60.2 Surgical Technique
- •61: Uveitis, Posterior
- •62: Vitreous Hemorrhage
- •62.1 General Considerations
- •62.2 Surgical Technique
- •62.3 Severe Bleeding in a Young Patient
- •62.4 Rebleeding in a Vitrectomized Eye
- •63: Trauma
- •63.1 The Timing of Surgery
- •63.2 Contusion
- •63.3 Wound Toilette
- •63.5 Suturing the Sclera
- •63.6 Subluxated Lens
- •63.7 IOFB
- •63.7.2 Posterior Segment
- •63.8 Perforating Trauma and Ruptures
- •63.9 NLP and Sympathetic Ophthalmia
- •63.11 Hemorrhagic RD
- •63.12 Additional Considerations
- •64: Postoperative Care
- •Further Reading
- •Appendix
- •Part 2. Important Personal Experiences
304 |
32 Working with Membranes |
|
|
•Forceps to grab and lift membranes.
•Scissors to lift membranes and/or cut42 membranes.
Viscodelamination and the probe are not reasonable options in dealing with PVR membranes. Bimanual surgery, however, is very helpful (see Sect. 24.2).
32.3.1.4 Surgical Steps
•Remove the lens if the eye is phakic.43
•Check if PVD has occurred (see below); if not, create one and carry it as anteriorly as possible.
Q&A
Q Is it acceptable if the creation of PVD causes retinal tears?
A It is preferable not to cause iatrogenic breaks. However, in diseases where the primary cause is traction, this may be a price worthwhile to pay if the vitreous can thus be separated from the retina. If a PVD cannot be created, retinectomy may be the next best option. The worst is to leave traction behind when breaks are also present.
•Find and remove all membranes.44
–This is much easier in the posterior pole than in the periphery.
–The membrane and the retina may adhere to each other as two sheets glued together, showing the crucial role the nondetached cortical vitreous plays in the process. If the membranes/posterior cortical vitreous complex is impossible to separate from the retina, the choice is between a retinectomy (see Sect. 33.1) and a SB (see Sect. 54.4).
•Check whether the retinal surface is now smooth; if not, the blood vessels remain corkscrew-like. Continue trying to identify and remove membranes until the retina is smooth.
–Remember that the cause may be a subretinal membrane.
•Using air or PFCL45, reattach the retina and check if it is under tension (air-test; see Sect. 31.1.2).
–If the retina does not readily reattach, remove the tamponade and continue searching for membranes or determine whether the retina is shortened and retinectomy is needed (see above).
•Repeat the F-A-X.
42Cutting (rather than removing) membranes is rarely done in anti-PVR surgery.
43Unless the patient is young, but even then sacrifice the lens if it prevents complete anterior vitrectomy.
44This is described in Sect. 32.2.
45See Chap. 35 for more details about tamponades.
32.3 Proliferative Membranes |
305 |
|
|
•If the retina is reattached and appears completely normal:
–Perform laser treatment.
–Fill the vitreous cavity with silicone oil.
32.3.1.5 Closed Funnel/Retinal Incarceration
It is crucial to remove all preand subretinal membranes if the surgeon wants to reattach a retina in an eye where the disc is invisible.46
•Remove the subretinal membranes first.
–Membranes may be broken in 2; with the adhesion to the photoreceptors now only at a single site, the membrane will cease causing traction and can be left behind.47
•A crucial area is close to the disc, where a ring proliferation may be present; without breaking up and removing this ring, the retina will not reattach but in cross section resemble a bell curve.
–Injecting PFCL over the choroid helps keeping the retina in a relatively stable position, allowing the surgeon to manipulate over the photoreceptors without the mobile funnel blocking the view every time a membrane is lifted.
•When no subretinal membranes are visible anymore, diathermize the anterior part of the funnel or the incarceration.
–Not all surgeons use diathermy; however, because of the risk of bleeding and its consequences,48 it is highly recommended.
–The line of diathermy spots may be too anterior; the final location of the line will be determined only after both the vitreous and all proliferative membranes will have been removed from the inside the funnel. The goal is to leave a central retina that is devoid of the gel (complete PVD) and any membranes on either side.
Pearl
If it is not only a closed funnel, but the retina is also incarcerated into the eyewall, I leave a small area, maybe 2 clock hours, incarcerated until all manipulations inside the funnel are also complete – this makes the retina much less mobile, aiding the manipulations.
•PFCL will not be able to open the funnel and provide access to the inside; the only option is to use cohesive visco such as Healon (see Sect. 13.3.2).
–Inject the Healon as posteriorly in the funnel as possible and very slowly. Its strength is sufficient to tear the retina if the membranes are very adherent.
46The surgeon is looking at the back surface of the retina in a closed-funnel detachment. Obviously, what is called “subretinal membrane” here is initially over the retinal surface according to the surgeon’s view.
47The air-test will help determine whether this is the case (see above).
48Increased risk of postoperative PVR.
306 |
32 Working with Membranes |
|
|
•Gradually remove the vitreous with the probe and all the membranes with forceps. The visco may have to be reinjected.
•When all the membranes are removed, cut the retina (see Chap. 33 for further details about retinotomy and retinectomy).
•Replace the visco with PFCL.
•If the retina is not completely flat or the retinal vessels remain distorted, look for more membranes on either surfaces of the retina.
•Perform laser treatment.
•Replace the PFCL with silicone oil.
32.3.1.6 ILM Removal
Removing the central ILM is the most important step in the prevention of new proliferation growing over the macula in case of PVR recurrence. As mentioned above (Sect. 32.1.4), always try to do the peeling in the largest possible area.
32.3.2 PDR49
Much of what has been described under Sect. 32.3.1 also applies for eyes with PDR. Only the significant differences are described below. Table 32.2 provides a direct comparison between the two conditions.
•Discuss with the patient what to do with the lens.50
–PPV-related cataract often presents later in diabetic eyes than it would in other conditions.
•Spontaneous PVD virtually never occurs in eyes with PDR, but the thin, membrane-like layer of cortical vitreous is invisible; only the behavior of the tissues being manipulated gives away its presence.
Q&A
Q How can the surgeon identify and remove this delicate membrane?
A The visible membranes are part of the anterior wall of this giant vitreoschisis cavity. Make an incision in the anterior wall just peripheral to the thick neovascular membrane. Use a barbed needle to pick up the thin epiretinal vitreous cortex, which may be multilayered and so adherent that the retina may get detached if blunt separation is attempted. Try carefully to extend the membrane detachment all the way to the periphery. Stop when the separation becomes impossible, hopefully before breaks appear. Any vitreous left behind must be further reduced via pneumovitrectomy (see Sect. 27.3.2), but always consider retinectomy as an option (see Sect. 33.1).
49With or without an RD component. More details are provided in Chap. 52.
50Retain it if the patient is young, but the lens should be sacrificed if it prevents complete anterior vitrectomy.
32.3 Proliferative Membranes |
|
307 |
|
|
|
Table 32.2 Comparing the eyes with PVR vs PDR |
|
|
Variablea |
PVR |
PDR |
Intraoperative hemorrhage, risk of |
Very small |
Significant, unless |
|
|
preoperative anti-VEGF |
|
|
injection is given |
Laser |
Focal + endolaser cerclage |
Panretinal |
Lens and IOL |
Remove it, unless the patient |
Consider removal, based on |
|
is very young, or if you |
the patient’s age and the |
|
do remove it, remove the |
eye’s condition |
|
capsules as well |
IOL implantation is usually |
|
Consider not implanting an |
done in the same setting |
|
IOL until the PVR |
|
|
process has stopped |
|
Macular involvement |
Common |
Rare |
Membrane removal |
Must be complete |
Segmentation is acceptableb |
Membrane removal, order of |
Up to the surgeon |
Start centrally and progress |
|
|
in a centrifugal direction |
Posterior location, predilection for |
No |
Yes |
PVD |
May be present posteriorly |
Extremely rare to be |
|
|
present; usually a |
|
|
vitreoschisis is found |
RD, combined |
Rare initially, often as part |
Rather common initially |
|
of a recurrence |
|
RD with closed-funnel |
Rather common |
Very rare* |
configuration |
|
|
Recurrence of the condition |
Common |
Less common, and it is |
|
|
usually PVR |
Retina fragile |
Rare |
Very common |
Retina highly elevated |
Rather common |
Very rare* |
Retinal break, iatrogenic during |
Rare |
Not uncommon |
surgery |
|
|
Strong adherence to retina |
Yes |
Yes |
Subretinal component |
Rare |
Rare |
Vascularization/bleeding |
Very rare |
Very common |
Vitreoschisis/multilayered |
Rare |
Very common |
membrane |
|
|
Vitreous attachment to membrane |
Mostly in the periphery |
Both posteriorly and in the |
|
|
periphery |
aIn alphabetical order.
bSee the text for more details.
*Occurs mostly when PVR develops as a postoperative complication.
–A surgeon who does not look for, and remove, this membrane neglects it at his own51 peril.
–Removal of the posterior wall (the “invisible” membrane) is much more difficult than that of the clearly visible membranes that form the anterior wall of the vitreoschisis cavity.
51 More importantly, at his patient’s.
308 |
32 Working with Membranes |
|
|
•The membranes in the anterior wall need not be completely removed.
–Complete removal is called delamination. This can be achieved using the tools and techniques described above but also by employing the probe at a high cut rate with a low aspiration/flow. Smaller-gauge probes and ones with a very distal port are especially excellent for this purpose. Viscoelastics may also be used, but they are less safe (see Sect. 13.3.1).
–Parts of the membrane may be circumcised: connections to adjacent areas are severed 360°. Such segmentation is especially useful when there is a risk of tearing the retina at this location with forceful removal/separation attempts. The membrane stump is diathermized and left behind.
–Bimanual surgery is especially beneficial in these eyes; typically, a forceps is held in the nondominant and the probe or scissors (spatula) in the dominant hand.
–The stump is also left on the disc, at least 1 mm in length. This allows the stump to be safely diathermized and prevents both intraand postoperative bleeding.
•Even if bevacizumab has been injected preoperatively (see Sect. 52.2), bleeding from newly formed or even normal-appearing vessels may occur. There are two related dilemmas for the surgeon: are you going to use diathermy? And if yes, when?
Q&A
Q Should all bleedings be diathermized?
A The rationale for using diathermy is that these bleedings are unlikely to spontaneously stop and especially to do so early, and the clot tends to adhere to the retina very strongly.
–Diathermy may be used on “continual” basis: every time there is a hemorrhage, the probe/forceps/scissors/spatula is exchanged for the diathermy probe, and the source of the bleeding is cauterized. The advantage of this technique is that all bleeding sources are easily identified and taken care of; the downside is that it requires numerous instrument exchanges.
–The alternative technique is to wait until all work is done and then cauterize the spots where bleeding still occurs. The advantage of this technique is that only a single instrument exchange is needed; the downside is that the blood rapidly coagulates in diabetes, and the clot may be difficult to remove. It may also adhere to the retina so strongly that it tears the retina upon being lifted.
Pearl
There may be vessels that do not bleed during surgery due to the elevated IOP intraoperatively; however, they will readily bleed postoperatively, causing disappointment both to the patient and surgeon. Try to provoke the bleeding during surgery by shutting off the infusion and aspirating some of the intravitreal fluid so that the IOP drops, and cauterize any hemorrhage that is observed. (In some machines the aspiration automatically restarts the infusion; in such cases use the flute needle to aspirate the fluid, not the probe.)
- #28.03.202639.38 Mб0The Wills eye manual office and emergency room diagnosis and treatment of eye disease Adam T. Gerstenblith, Michael P. Rabinowitz.chm
- #
- #
- #
- #
- #
- #
- #28.03.202614.01 Кб0[Офтальмология] Jack J. Kanski Джек Дж. Кански - Клиническая офтальмология систематизированный подход [2006, PDF DjVu, RUS] [rutracker-5395873].torrent
- #
- #
- #
